Latest News
Jui Dave, PhD, an associate research scientist in the Greif Lab, was awarded a Career Development Award from the American Heart Association.
- August 05, 2022
Inamul Kabir, PhD, was selected for a Career Development Award (2022-2025) from the American Heart Association.
- February 10, 2022Source: Tech Explorist
New insights into the molecular and cellular development of a rare heart defect.
- February 08, 2022
A Yale-led study provides new insights into the molecular and cellular development of supravalvular aortic stenosis (SVAS).
- December 10, 2021
A Yale-led study provides new insights into the molecular and cellular development of idiopathic pulmonary fibrosis (IPF), a lethal lung disease that has been diagnosed with increased frequency.
- May 18, 2021
Daniel Greif, MD, has been appointed as the vice chair (2021-2022) and chairman-elect (2022-2023) of the Scientific Committee for Sarnoff Cardiovascular Research Foundation.
- September 16, 2019
There have been 121 faculty appointments and promotions across 11 sections in the Department of Internal Medicine since September of 2018.
- April 05, 2019
The American Heart Association has awarded to Daniel Greif, MD a grant to study the mechanisms of reverse vascular remodeling in pulmonary hypertension.
- May 25, 2018
In a new study, Yale researchers investigate how plaque cells develop at the molecular level, and their findings could help produce targeted treatments for the disease.
- April 24, 2018
Pulmonary hypertension is a type of high blood pressure that affects blood vessels in the lungs. Once diagnosed, patients have limited treatment options, and many do not live beyond seven years. In a new study, scientists in the Yale Cardiovascular Research Center have gained new insight into the development of the disease that could lead to new therapies.